Blood Advances (Dec 2024)

Mitani K, Lee JW, Jang JH, et al. Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study. Blood Adv. 2024;8(6):1415-1419.